UK Platelet Rich Plasma (prp) Market Size & Outlook
UK platelet rich plasma (prp) market, 2018-2030 (US$M)
Related Markets
UK platelet rich plasma (prp) market highlights
- The UK platelet rich plasma (prp) market generated a revenue of USD 40.9 million in 2023 and is expected to reach USD 123.0 million by 2030.
- The UK market is expected to grow at a CAGR of 17% from 2024 to 2030.
- In terms of segment, pure prp was the largest revenue generating type in 2023.
- Leukocyte Rich PRP is the most lucrative type segment registering the fastest growth during the forecast period.
Platelet rich plasma (prp) market data book summary
| Market revenue in 2023 | USD 40.9 million |
| Market revenue in 2030 | USD 123.0 million |
| Growth rate | 17% (CAGR from 2023 to 2030) |
| Largest segment | Pure prp |
| Fastest growing segment | Leukocyte Rich PRP |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Pure PRP, Leukocyte Rich PRP |
| Key market players worldwide | Johnson & Johnson, Arthrex, Terumo Corp, Zimmer Biomet Holdings Inc, Stryker Corp, EmCyte Corporation, Dr. PRP USA, Juventix Regenerative Medical, APEX Biologix, Celling Biosciences |
Other key industry trends
- In terms of revenue, UK accounted for 6.3% of the global platelet rich plasma (prp) market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, UK platelet rich plasma (prp) market is projected to lead the regional market in terms of revenue in 2030.
- UK is the fastest growing regional market in Europe and is projected to reach USD 123.0 million by 2030.
Pure prp was the largest segment with a revenue share of 51.83% in 2023. Horizon Databook has segmented the UK platelet rich plasma (prp) market based on pure prp, leukocyte rich prp covering the revenue growth of each sub-segment from 2018 to 2030.
In the UK, PRP treatment has emerged as a promising, nonsurgical option for patients with knee osteoarthritis. Various studies by UK researchers have suggested that the use of PRP in combination with hyaluronic acid can provide pain relief. Such supportive research studies are expected to boost the adoption of PRP treatments in the country, which can lead to lucrative market growth in the coming years.
Furthermore, the National Institute for Health and Care Excellence (NICE) provided guidance for PRP injections for knee osteoarthritis in January 2019. This guidance includes evidence-based recommendations for PRP injections for knee osteoarthritis.
Moreover, several clinics, such as The Regenerative Clinic & HCA Healthcare UK, are involved in offering PRP treatments to patients. Such service providers are expected to positively impact the market growth in the country.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Platelet Rich Plasma (PRP) Market Scope
Platelet Rich Plasma (PRP) Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
UK platelet rich plasma (prp) market size, by type, 2018-2030 (US$M)
UK Platelet Rich Plasma (PRP) Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
